Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from China Everbright ( (HK:0165) ).
China Everbright Limited has announced the appointment of Dr. Young Danqing Xu as an Independent Non-executive Director, effective from June 25, 2025. Dr. Young will also join several board committees, enhancing the company’s governance and diversity. Her appointment aligns with upcoming changes in the Listing Rules and Corporate Governance Code, which emphasize gender diversity and effective board practices. The company believes Dr. Young’s extensive experience in accounting and academia will bring valuable insights and innovations to the board, strengthening its overall effectiveness.
More about China Everbright
China Everbright Limited is a Hong Kong-based company operating in the financial services industry. It provides a range of services including asset management, investment banking, and private equity, focusing on leveraging its expertise to serve the Greater China region and beyond.
Average Trading Volume: 22,424,418
Technical Sentiment Signal: Buy
Current Market Cap: HK$9.84B
For an in-depth examination of 0165 stock, go to TipRanks’ Overview page.